Rigel Pharmaceuticals Stock

Rigel Pharmaceuticals Debt 2024

Rigel Pharmaceuticals Debt

26.82 USD

Ticker

RIGL

ISIN

US7665596034

WKN

766093

In 2024, Rigel Pharmaceuticals's total debt was 26.82 USD, a 79.97% change from the 14.9 USD total debt recorded in the previous year.

Rigel Pharmaceuticals Aktienanalyse

What does Rigel Pharmaceuticals do?

Rigel Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of drugs for the treatment of autoimmune diseases, inflammation, and cancer. It was founded in 1996 by Donald Payan. The company is headquartered in South San Francisco, California. Rigel Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Rigel Pharmaceuticals's Debt Structure

Rigel Pharmaceuticals's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Rigel Pharmaceuticals's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Rigel Pharmaceuticals’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Rigel Pharmaceuticals’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Rigel Pharmaceuticals stock

What is the debt of Rigel Pharmaceuticals this year?

Rigel Pharmaceuticals has a debt level of 26.82 USD this year.

What was the debt of Rigel Pharmaceuticals compared to the previous year?

The debt of Rigel Pharmaceuticals has increased by 79.97% compared to the previous year increased.

What are the consequences of high debt for investors in Rigel Pharmaceuticals?

High debt can pose a risk for investors of Rigel Pharmaceuticals, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Rigel Pharmaceuticals?

Low debt means that Rigel Pharmaceuticals has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Rigel Pharmaceuticals affect the company?

An increase in debt of Rigel Pharmaceuticals can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Rigel Pharmaceuticals affect the company?

A reduction in debt of Rigel Pharmaceuticals can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Rigel Pharmaceuticals?

Some factors that can influence the debt of Rigel Pharmaceuticals include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Rigel Pharmaceuticals so important for investors?

The debts of Rigel Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Rigel Pharmaceuticals take to change the debt?

To change the debt, Rigel Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Rigel Pharmaceuticals pay?

Over the past 12 months, Rigel Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Rigel Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Rigel Pharmaceuticals?

The current dividend yield of Rigel Pharmaceuticals is .

When does Rigel Pharmaceuticals pay dividends?

Rigel Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Rigel Pharmaceuticals?

Rigel Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Rigel Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Rigel Pharmaceuticals located?

Rigel Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Rigel Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rigel Pharmaceuticals from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Rigel Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Rigel Pharmaceuticals in the year 2023?

In the year 2023, Rigel Pharmaceuticals distributed 0 USD as dividends.

In which currency does Rigel Pharmaceuticals pay out the dividend?

The dividends of Rigel Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Rigel Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Rigel Pharmaceuticals

Our stock analysis for Rigel Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rigel Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.